Dipyridamole thallium-201 scintigraphy for early risk stratification of patients after uncomplicated myocardial infarction

Heart

Volumn 78, Issue 4, 1997, Pages 346-352

  Hung, Joseph ^a,c   Moshiri, Mehdi ^b   Groom, Geoffrey N ^b   Van Der Schaaf, Agatha A ^b   Parsons, Richard W ^a   Hands, Mark E ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Dipyridamole; Myocardial infarction; Prognosis; Thallium

Indexed keywords

DIPYRIDAMOLE; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; RISK ASSESSMENT; SAFETY; TREATMENT PLANNING;

EID: 0030724713     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.4.346     Document Type: Article

References (31)

1. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 1990; 335:427-31.
2. Schroder R, Neuhaus K-L, Linderer T, Leizorovicz A, Wegscheider K, Tebbe U. Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) study. Circulation 1987; 76(suppl II):II-44-51.
3. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol 1995;26:66-72.
4. Rapaport E, Remedios P. The high risk patient after recovery from myocardial infarction: recognition and management. J Am Coll Cardtol 1983;1:391-400.
5. DeBusk RF, Kraemer HC, Nash E, Lew H. Stepwise risk stratification soon after acute MI. Am J Cardiol 1983;52: 1161-6.
6. Moss AJ, Benhorn J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990;322:743-53.
7. Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala JF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301:341-5.
8. Sami M, Kraemer H, De Busk RF. The prognostic significance of serial exercise testing after myocardial infarction. Circulation 1979; 60:1238-46.
9. Starling MR, Crawford MH, Kennedy GT, O'Rourke RA. Exercise testing after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol 1980;46:909-14.
10. Weld FM, Chu K-L, Bigger JTJ, Rolnitzky LM. Risk stratification with low-level exercise testing 2 weeks after acute myocardial infarction. Circulation 1981;64:306-14.
11. DeBusk RF. Specialized testing after recent myocardial infarction. Ann Intern Med 1989;110:470-81.
12. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321-36.
13. Hung J, Goris ML, Nash E, Kraemer HC, De Bush RF, Berger WE, et al. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction. Am J Cardiol 1984;53:1221-7.
14. Legrand V, Rigo P, Kulbertus HE. Complementary role of thallium-201 scintigraphy to pre-discharge exercise electrocardiography for patient stratification after a first myocardial infarction. Eur Heart J 1986;7:644-53.
15. Leppo JA. Dipyridamole-thallium imaging: the lazy man's stress test. J Nucl Med 1989;30:281-7.
16. Beer SG, Heo J, Iskandrian AS. Dipyridamole thallium imaging. Am J Cardiol 1991;67:18-26D.
17. Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-8.
18. Pirelli S, Inglese E, Suppa M, Corrada E, Campolo L. Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction.) Eur Heart J 1988;9:1324-31.
19. Younis LT, Byers S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event. Am J Cardiol 1989;64:161-6.
20. Gimple LW, Hutter AM, Guiney TE, Boucher CA. Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol 1989;64:1243-8.
21. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990;65:160-7.
22. Smart RC, Burke JJ, Lyons NR. Thallium circumferential profiles in the detection of coronary artery disease-assessment by receiver operating characteristic curve analysis. Eur J Nucl Med 1986;12:9-15.
23. Hutton BF, Cormack J, Fulton RR. A software package for the analysis of gated blood pool studies. Aust Phys Eng Sci Med 1982;5:128-34.
24. Mahmarian JJ, Pratt CM, Nishimura S, Abreu A, Verani MS. Quantitative adenosine 201 T1 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993;87: 1197-210.
25. Bonow RO, Dilsizian V. Assessing viable myocardium with thallium-201. Am J Cardiol 1992;70:10-17E.
26. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
27. Schuster EH, Bulkley BH. Early post-infarction angina: ischemia at a distance and ischemia in the infarct zone. N Engl J Med 1981;305:1101-5.
28. Abraham RD, Freedman SB, Dunn RF, Newman H, Roubin RS, Harris PJ, et al. Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning. Am J Cardiol 1986;58:423-7.
29. Satler LF, Pallas RS, Bond OB, Green CE, Pearle DL, Schaer GL, et al. Assessment of residual coronary artery stenosis after thrombolytic therapy during acute myocardial infarction. Am J Cardiol 1987;59:1231-3.
30. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
31. Iskandrian AS, Heo J, Askenase A, Segal BL, Helfant RH. Thallium imaging with single photon emission computed tomography. Am Heart J 1990;110:135-43.